571P Preclinical evaluation of FAP-2286, a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP)
Dirk Zboralski, Frank Osterkamp, Andrew D. Simmons, Anne Bredenbeck, A. Schumann, Matthias Paschke, Nicola Beindorff, Ajay-Mohan Mohan, Minh Nguyen, Jim Xiao, Thomas C. Harding, Aileen Hoehne, Ulrich Reineke, Christiane Smerling
Topics & Concepts
Fibroblast activation protein, alphaIn vivoMedicineBiodistributionImmunohistochemistryIn vitroDOTACancer researchPathologyCancerChemistryInternal medicineBiologyBiochemistryBiotechnologyPeptidase Inhibition and AnalysisRadiopharmaceutical Chemistry and ApplicationsNeuropeptides and Animal Physiology